| Application no. and date | 18206943.5 (espacenet) (Federated) (European Patent Register), 20140903 | | Patent/reg. no. and date | DK/EP 3483163, 20210623 | | Publication date | 20190515 | | Priority no. and date | EP 13183385, 20130906 | | EP pub. no. and date |
EP 3483163 20190515 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P77468DK01 | | Inventor | GRETHER, Uwe, Kirchgasse 4
79588 Efringen-Kirchen, DE,
NETTEKOVEN, Matthias, Ruetteweg 3
79639 Grenzach-Wyhlen, DE,
ROGERS-EVANS, Mark, Rosenweg 6
4103 Bottmingen, CH,
ROEVER, Stephan, Auf der Neusetze 19
79594 Inzlingen, DE,
SCHMITT, Sebastien, 9 rue de l'Eglise
68220 Hagenthal-le-Bas, FR,
KIMBARA, Atsushi, c/o Chugai Pharmaceutical Co., Ltd
1-135 Komakado Gotemba
Shizuoka, 412-8513, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 29/00 (2006.01) , C07D 487/04 (2006.01) | | Title | Triazolo[4,5-d]pyrimidinderivater som cb2-receptorantagonister | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
